Phase 2 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You (or your child) have been diagnosed with a specific type of brain tumor (a form of glioblastoma or related high-grade brain tumor) confirmed by laboratory testing, including cases where the tumor has spread or affects multiple areas of the brain
- This is a first-time diagnosis and the tumor has not yet been treated with chemotherapy or radiation — surgery alone is acceptable
- The patient is between 3 and 30 years old (male or female)
- The patient is expected to live for at least 12 months
- The patient is generally functioning well in daily life, scoring 80% or above on a standard health performance scale (confirm with trial site)
- Blood counts are within acceptable levels — enough white blood cells, red blood cells, and platelets
- The liver is functioning adequately, based on standard blood test results
- The kidneys are functioning adequately, based on standard blood test results
- The patient, their parents, or legal guardians are able to sign a written consent form agreeing to take part
- The patient is willing and able to follow the trial's treatment plan and schedule
Who may not be able to join:
- The patient has another serious illness or condition that would make the trial treatment unsafe — for example, severe heart disease, severe cerebral palsy, or severe congenital conditions
- The patient is already receiving a first course of chemotherapy at the time of joining the trial
- The patient is currently taking part in another research study
- The patient is pregnant or breastfeeding
- The patient is not using an appropriate method of contraception (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Iacopo Sardi, Meyer Children's Hospital IRCCS
Phone: 0555662631
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation prolonged Dox; Percentage of Withdrawal from the study rate; Percentage of SAEs; Mortality rate; Early discontinuation of dox treatment rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.